Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer [Phase 1, Phase 2]
The document reports a completed Phase 1/2 clinical trial evaluating a vaccine therapy plus interleukin-2 in women with advanced breast or o…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 vaccine therapy trial for ovarian, fallopian tube, and primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update on thalidomide for patients with refractory or resistant epithelial ovarian cancer. The trial status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1]
This document reports the completion of a Phase 1 trial evaluating taurolidine in patients with recurrent ovarian epithelial cancer, fallopi…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Phase 2]
A Phase 2 trial evaluating the combination of bicalutamide and goserelin in ovarian cancer, fallopian tube cancer, or primary peritoneal can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-17FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for cyclophosphamide from Civica, Inc. under ANDA 040745.
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer [Phase 2]
This clinical trial update indicates the Phase 2 study of sorafenib tosylate plus gemcitabine hydrochloride in recurrent ovarian epithelial …
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
A clinical trial update summarizes the observed incidence of thromboembolism in patients receiving chemotherapy for solid tumors, across bre…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine and topotecan for refractory or recurrent ovarian cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 [NA]
Withdrawn clinical trial update for GOG-172 evaluating paclitaxel plus cisplatin in stage III ovarian cancer. No results or economic outcome…
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin [Phase 2]
A Phase 2 trial of gemcitabine and carboplatin for persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peri…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk [NA]
A clinical trial comparing fenretinide followed by preventive surgery versus preventive surgery alone in women at high risk for ovarian canc…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [Phase 2]
Phase 2 trial update of etoposide in advanced ovarian or cervical cancer has been terminated. The study was sponsored by the Gynecologic Onc…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating liposomal doxorubicin and etoposide in recurrent or persistent ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS research · 2013-06-10Clinical Trial Update: Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer [NA]
Clinical trial to screen individuals at high genetic risk for ovarian cancer, sponsored by Massachusetts General Hospital. The trial status …
-
CLINICAL_TRIALS research · 2013-06-10Clinical Trial Update: Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
A clinical trial update indicates the quality-of-life study in patients with previously treated ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial of an investigational Tarix Pharmaceuticals agent to reduce chemotherapy-induced thrombocytopenia in patients with ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin [Phase 2]
Phase 2 trial of temozolomide in patients with metastatic germ cell tumors that did not respond to cisplatin has been completed.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating a monoclonal antibody vaccine therapy for ovarian epithelial, fallopian tube, and primary peritoneal cancers has co…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index
This is a pilot test of a synoptic operative template for ovarian cancer using the Peritoneal Carcinomatosis Index, sponsored by the Nationa…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women [Phase 2]
A Phase 2 trial evaluating pazopanib monotherapy after first-line chemotherapy in Asian women with ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining interleukin-12, paclitaxel, and trastuzumab in patients with vario…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Preference Study With Elderly Patients Recurrent Ovarian Cancer [Phase 3]
A Phase 3 preference study in elderly patients with recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer [Phase 2]
This document provides an update on a Phase 2 trial evaluating the combination chemotherapy with bone marrow transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial (CT-2103) evaluated CT-2103 in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or prima…